Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates

被引:20
作者
Martinac, A
Filipovic-Grcic, J
Barbaric, M
Zorc, BK
Voinovich, D
Jalsenjak, I
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
[2] Univ Trieste, Fac Pharm, Dept Pharmaceut Sci, I-34127 Trieste, Italy
关键词
chitosan microspheres; macromolecular conjugates; gemfibrozil; sustained release; poly[(alpha; beta-(N-2-hydroxyethyl-DL-aspartamide); poly[alpha; beta-(N-3-hydroxypropyl-DL-aspartamide);
D O I
10.1016/S0928-0987(02)00190-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to evaluate and compare the ability of the macromolecular conjugates and microspheres to modify the release rate of gemfibrozil (Gem). Gem was covalently linked to two similar polymers: poly [alpha,beta-(N-2-hydroxyethyl-DL-aspartamide)] (PHEA) and poly [alpha,beta-(N-3-hydroxypropyl-DL-aspartamide)] (PHPA) by an ester linkage. The polymer-drug conjugates obtained (PHEA-G(1-3) and PHPA-G) differ in weight-average molecular weight, length of spacer and Gem content. Microspheres, composed of chitosans of different molecular weight alone or as a mixture with (2-hydroxypropyl)methylcellulose (HPMC), PHEA or PHPA and with different theoretical polymer/drug ratio (2:1 and 3:1, w/w) were prepared by spray drying. The microparticulate systems were morphologically characterised by scanning electron microscopy, particle size analysis and Gem content was determined. In vitro dissolution tests were performed to evaluate the feasibility of conjugates and microspheres in modulating Gem release. The results obtained show that microspheres are always suitable to modulate Gem release and that the best conditions are achieved by microspheres composed of the low molecular weight chitosan (CL) combined with PHPA or HPMC with either 2:1 or 3:1 (w/w) polymer/drug ratio. The PHEA-G conjugates exhibited rapid Gem release within less than 2 It, while the PHPA-G conjugate showed sustained Gem release profiles over a 10-h period. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 23 条
  • [1] [Anonymous], J POLYM SCI, V2021, P59
  • [2] HYDRODYNAMIC PROPERTIES OF A NEW PLASMA EXPANDER - POLYHYDROXYETHYLASPARTAMIDE
    ANTONI, G
    NERI, P
    PEDERSEN, TG
    OTTESEN, M
    [J]. BIOPOLYMERS, 1974, 13 (09) : 1721 - 1729
  • [3] DROBNIK J, 1979, J POLYM SCI PS, V66, P65
  • [4] POLYMER CONJUGATES - PHARMACOKINETIC CONSIDERATIONS FOR DESIGN AND DEVELOPMENT
    DUNCAN, R
    SPREAFICO, F
    [J]. CLINICAL PHARMACOKINETICS, 1994, 27 (04) : 290 - 306
  • [5] Furda I., 2000, CHITOSAN OS DIETARY, P41
  • [6] SYNTHESIS AND THERAPEUTIC POTENTIAL OF A MACROMOLECULAR PRODRUG OF DIFLUNISAL
    GIAMMONA, G
    CAVALLARO, G
    PITARRESI, G
    VENTURA, C
    PALAZZO, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 105 (01) : 57 - 63
  • [7] GIAMMONA G, 1995, J CONTROL RELEASE, V33, P261, DOI 10.1016/0168-3659(94)00091-8
  • [8] Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies
    Giammona, G
    Cavallaro, G
    Fontana, G
    Pitarresi, G
    Carlisi, B
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) : 321 - 331
  • [9] HOEFLE ML, 1981, Patent No. 4285951
  • [10] Jakopovic M, 1996, CROAT CHEM ACTA, V69, P267